Verrica Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Verrica Pharmaceuticals Inc. (VRCA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 27.52 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 27.52M shares, a 7.49% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 27.52M shares, a 9.82% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 27.52M shares, a 10.11% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 27.51M shares, a 10.21% increase year-over-year.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 27.04M shares, a 8.20% increase from fiscal 2020.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 25.00M shares, a 0.39% increase from fiscal 2019.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 24.90M shares, a 69.80% increase from fiscal 2018.
- Verrica Pharmaceuticals Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 14.66M shares, a 414.43% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 27.52M shares 10-Q · filed 2022-05-09 | 27.52M shares derived: average of 2 quarters · filed 2022-05-09 | 27.52M shares derived: average of 3 quarters · filed 2022-05-09 | 27.52M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 27.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | 27.52M shares derived: average of 2 quarters · filed 2022-03-02 | 27.52M shares derived: average of 3 quarters · filed 2022-03-02 | 27.04M shares 10-K · filed 2022-03-02 |
| 2021-09-30 | 27.52M shares 10-Q · filed 2021-11-12 | 27.52M shares derived: average of 2 quarters · filed 2021-11-12 | 26.88M shares 10-Q · filed 2021-11-12 | 26.42M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-06-30 | 27.51M shares 10-Q · filed 2021-08-10 | 27.70M shares 10-Q · filed 2021-08-10 | 26.06M shares derived: average of 3 quarters · filed 2022-05-09 | 25.79M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-03-31 | 25.60M shares 10-Q · filed 2022-05-09 | 25.33M shares derived: average of 2 quarters · filed 2022-05-09 | 25.22M shares derived: average of 3 quarters · filed 2022-05-09 | 25.16M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 25.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | 25.03M shares derived: average of 2 quarters · filed 2022-03-02 | 25.01M shares derived: average of 3 quarters · filed 2022-03-02 | 25.00M shares 10-K · filed 2022-03-02 |
| 2020-09-30 | 24.99M shares 10-Q · filed 2021-11-12 | 24.98M shares derived: average of 2 quarters · filed 2021-11-12 | 24.97M shares 10-Q · filed 2021-11-12 | 24.96M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | 24.97M shares 10-Q · filed 2021-08-10 | 24.96M shares 10-Q · filed 2021-08-10 | 24.95M shares derived: average of 3 quarters · filed 2021-08-10 | 24.94M shares derived: average of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | 24.96M shares 10-Q · filed 2021-05-07 | 24.94M shares derived: average of 2 quarters · filed 2021-05-07 | 24.93M shares derived: average of 3 quarters · filed 2021-05-07 | 24.91M shares derived: average of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | 24.92M shares 10-K · filed 2020-03-13 | 24.91M shares derived: average of 2 quarters · filed 2020-11-09 | 24.90M shares derived: average of 3 quarters · filed 2020-11-09 | 24.90M shares 10-K · filed 2021-03-17 |
| 2019-09-30 | 24.89M shares 10-Q · filed 2020-11-09 | 24.88M shares derived: average of 2 quarters · filed 2020-11-09 | 24.88M shares 10-Q · filed 2020-11-09 | 24.87M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 24.88M shares 10-Q · filed 2020-08-05 | 24.87M shares 10-Q · filed 2020-08-05 | 24.86M shares derived: average of 3 quarters · filed 2020-08-05 | 24.86M shares derived: average of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | 24.86M shares 10-Q · filed 2020-05-07 | 24.85M shares derived: average of 2 quarters · filed 2020-05-07 | 24.85M shares derived: average of 3 quarters · filed 2020-05-07 | 20.08M shares derived: average of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | 24.85M shares 10-K · filed 2020-03-13 | 24.85M shares derived: average of 2 quarters · filed 2020-03-13 | 18.48M shares derived: average of 3 quarters · filed 2020-03-13 | 14.66M shares 10-K · filed 2020-03-13 |
| 2018-09-30 | 24.85M shares 10-K · filed 2020-03-13 | 15.30M shares derived: average of 2 quarters · filed 2020-03-13 | 11.23M shares 10-Q · filed 2019-11-06 | 9.07M shares derived: average of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | 5.75M shares 10-K · filed 2020-03-13 | 4.31M shares 10-Q · filed 2019-08-07 | 3.82M shares derived: average of 3 quarters · filed 2020-03-13 | 3.58M shares derived: average of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | 2.85M shares 10-K · filed 2020-03-13 | 2.85M shares derived: average of 2 quarters · filed 2020-03-13 | 2.85M shares derived: average of 3 quarters · filed 2020-03-13 | 2.85M shares derived: average of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | 2.85M shares 10-K · filed 2019-03-07 | 2.85M shares derived: average of 2 quarters · filed 2019-03-07 | 2.85M shares derived: average of 3 quarters · filed 2019-03-07 | 2.85M shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 2.85M shares 10-K · filed 2019-03-07 | 2.85M shares derived: average of 2 quarters · filed 2019-03-07 | 2.85M shares 10-Q · filed 2018-11-07 | |
| 2017-06-30 | 2.85M shares 10-K · filed 2019-03-07 | 2.85M shares 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | 2.85M shares 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |